Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3681-x
Abstract: PurposeThis study aimed to identify a biomarker for predicting the response to sorafenib in patients with hepatocellular carcinoma (HCC).MethodsOf 100 patients with unresectable HCC who received sorafenib treatment in our institute (Cohort A), 48 had… read more here.
Keywords: response; treatment; cohort; response sorafenib ... See more keywords
Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot Study.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Computer Assisted Tomography"
DOI: 10.1097/rct.0000000000000866
Abstract: PURPOSE This pilot study evaluates the feasibility of automated volumetric quantification of hepatocellular carcinoma (HCC) as an imaging biomarker to assess treatment response for sorafenib. METHODS In this institutional review board-approved, Health Insurance Portability and… read more here.
Keywords: hepatocellular carcinoma; response sorafenib; automated volumetric; study ... See more keywords